Webinar - Theranostics and PET Imaging Diagnostics

Please register to watch the webinar recording

What will you learn from the webinar ?

  • Use of PET Imaging companion radiopharmaceutical in theranostics - By Dr. Lisa Bodei

Dr Bodei will give an introduction on the use of PET radiopharmaceuticals in Theranostic applications and she will provide a synopsis of the major clinical trials. She will also share future perspectives in this field.

  • Evolving evidence-base for PSMA Theranostics to improve outcomes for men with prostate cancer - By Prof. Michael Hofman

Prof. Hofman will deep dive into PSMA theranostics, a new treatment platform for men with advanced prostate cancer. He will explore the evolving evidence base, discuss different methodologies for patient selection and treatment logistics.


  • Dr. Lisa Bodei

    MD, PhD Lisa Bodei, MD, PhD, Director of Targeted Radionuclide Therapy, Molecular Imaging and Therapy Service, Department of Radiology at Memorial Sloan Kettering Cancer Center.

  • Prof. Michael Hofman

    Professor Michael Hofman, nuclear medicine physician at the Peter MacCallum Cancer Centre in Melbourne.